UncategorizedDerisking clinical trials requires a ‘human first’ approach Empower Meds / October 23, 2025
UncategorizedTruDiagnostic links Ozempic ingredient to slower biological aging – Longevity.Technology Empower Meds / October 23, 2025
UncategorizedCND Life Sciences receives $3 million NIH grant for Parkinson’s risk study – Longevity.Technology Empower Meds / October 23, 2025
UncategorizedAlector halts latozinemab programme after phase 3 fails key clinical endpoint – Longevity.Technology Empower Meds / October 23, 2025
UncategorizedLifeist relaunches Mikra products on Amazon to boost U.S. access – Longevity.Technology Empower Meds / October 23, 2025
UncategorizedAdaptyx lands $14m for continuous monitoring of multiple health markers Empower Meds / October 22, 2025
UncategorizedRejuve.ai launches longevity athlete challenge at Infinite Games Empower Meds / October 22, 2025
UncategorizedHaut.AI launches GenAI-powered skin aging simulation – Longevity.Technology Empower Meds / October 22, 2025
UncategorizedTelomir Pharmaceuticals secures worldwide rights to Telomir-1 with binding LOI – Longevity.Technology Empower Meds / October 22, 2025
